Gritstone bio, Inc. ( GRTS) - Key Metrics
Stock symbol GRTS is outdated, potentially delisted? Maybe it is available on other exchange?
GRTS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $0 | -$0.16 | -$0.19 | -$0.19 |
| 2024Q1 | $0 | -$0.34 | -$0.28 | -$0.28 |
| 2023Q4 | $0 | -$0.32 | -$0.35 | -$0.35 |
| 2023Q3 | $0.01 | -$0.33 | -$0.27 | -$0.28 |
| 2023Q2 | $0 | -$0.31 | -$0.27 | -$0.28 |
GRTS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -0.89 |
| 2024Q1 | ? | -1.72 |
| 2023Q4 | -2.41% | -1.61 |
| 2023Q3 | ? | -1.29 |
| 2023Q2 | ? | -1.59 |
GRTS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q2 | -32.30% | ? |
| 2024Q1 | -12.12% | ? |
| 2023Q4 | -17.36% | 0.37% |
| 2023Q3 | -16.22% | ? |
| 2023Q2 | -14.58% | ? |
GRTS
Price: $0.03
52 week price:
Earnings Per Share: -1.09 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 427892
Market Capitalization: 3.8 million